Raffaella Viti
ScholarGPS® ID: 66643449594266
Affiliation History
Field
Social Sciences
Discipline
Economics
Top Specialties
Italy | Diabetes | Technology Assessment | Economic Evaluation | Health Technology Assessment
Metrics Summary
Publication Count
41
Predicted Citations
1,105
Predicted h-index
17
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
[Burden of Short Bowel Syndrome in Italy: Direct and Indirect Costs and Quality of Life] (journal article) Farmeconomia. Health economics and therapeutic pathways, volume 24, issue 1 (2023). |
Expert Review of Pharmacoeconomics & Outcomes Research, volume 19, issue 5, pages 581-599 (2019). |
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data (journal article) PharmacoEconomics, volume 37, issue 2, pages 255-266 (2019). |
Reproductive Biology and Endocrinology, volume 16, issue 1 (2018). |
PIN79 - ECONOMIC CONSEQUENCES OF ANTI-HCV ANTIVIRAL TREATMENT INVESTMENT FROM THE NHS PERSPECTIVE: A REAL-WORLD-BASED ANALYSIS FROM PITER DATA (journal article) Value in Health, volume 21 (2018). |
Clinical Drug Investigation, volume 38, issue 10, pages 955-965 (2018). |
Economic burden of disease of uncontrolled acromegalic patients: the acromegaly Italian collaborative study group (journal article) Global and Regional Health Technology Assessment, volume 5, issue 1 (2018). |
Economic burden of schizophrenia in Italy: a probabilistic cost of illness analysis (journal article) BMJ Open, volume 8, issue 2, pages e018359- (2018). |
Economic evaluation of spondyloarthritis: economic impact of diagnostic delay in Italy (journal article) ClinicoEconomics and Outcomes Research, volume Volume 10 (2018). |
Economic burden of disease of uncontrolled acromegalic patients: the acromegaly Italian collaborative study group (journal article) Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish, volume 2018 (2018). |
PD56 Economic Evaluation Of Dalbavancin In European Countries (journal article) International Journal of Technology Assessment in Health Care, volume 34, issue S1, pages 149-150 (2018). |
Budget Impact analysis of the first-line treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) adult patients (journal article) Farmeconomia. Health economics and therapeutic pathways, volume 18, issue 1 (2017). |
Economic aspects in the management of diabetes in Italy (journal article) BMJ Open Diabetes Research & Care, volume 4, issue 1, pages e000197- (2016). |
The PPARγ2 P12A polymorphism is not associated with all-cause mortality in patients with type 2 diabetes mellitus (journal article) Endocrine, volume 54, issue 1, pages 38-46 (2016). |
Clinical Drug Investigation, volume 36, issue 8, pages 661-672 (2016). |
Early Treatment in HIV Patients: A Cost–Utility Analysis from the Italian Perspective (journal article) Clinical Drug Investigation, volume 36, issue 5, pages 377-387 (2016). |
Global and Regional Health Technology Assessment, volume 3, issue 1, pages 42-47 (2016). |
The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach (journal article) The European Journal of Health Economics, volume 17, issue 2, pages 139-147 (2016). |
Early Treatment in HCV: Is it a Cost-Effective Option from the Italian Perspective? (journal article) SSRN Electronic Journal (2016). |
Global & Regional Health Technology Assessment, volume 3, issue 1, pages GRHTA.5000216- (2016). |